Proteus mirabilis, a Gram-negative bacterium belonging to the family Enterobacteriaceae, is a common cause of urinary tract infections. Phages infecting Proteus mirabilis could be used as therapeutics to treat infections caused by this bacterium. This announcement describes the complete genome sequence of the T5like P. mirabilis phage Stubb. P roteus mirabilis is a Gram-negative pathogen that often causes symptomatic infections, such as cystitis and pyelonephritis, and asymptomatic bacteriuria (1, 2). With the reportedly increased rate of antibiotic resistance among P. mirabilis strains (3) and the promising in vitro treatment results of catheters with phage cocktails (4), phage therapy against P. mirabilis may prove useful in treating infections caused by this bacterium.
Proteus phage Stubb was assembled at 27.8-fold coverage to a single contig of 104,410 bp, with only one copy of a 11,415-bp direct terminal repeat determined by PhageTerm (19) . It has a GϩC content of 38.5%. The progressiveMauve program (20) was used to compare Stubb nucleotide similarity against the NCBI nr/nucleotide database, and the most similar organism at 83.9% identity was Proteus phage PM135 (GenBank accession no. NC_042090). Despite having a nucleotide similarity of only 19.8% with T5 (GenBank accession no. AY543070), the Stubb genome appears to be syntenic with the T5 genome (21) . Most of the genes with a predicted function were involved in phage morphogenesis and in DNA replication. Lysis genes encoding a class III holin and endolysin with a hydrolase domain and an overlaping spanin pair were identified.
Data availability. The genome sequence of phage Stubb was deposited under GenBank accession no. MH830339. The associated BioProject, SRA, and BioSample accession numbers are PRJNA222858, SRR8771457, and SAMN11234224, respectively.
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